[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100455038":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":25,"centralContacts":29,"locations":34,"responsibleParty":97,"collaborators":10,"id":99,"slug":100,"hasResults":101,"nctId":102,"briefTitle":103,"officialTitle":103,"acronym":10,"eligibilityCriteria":104,"healthyVolunteers":101,"sex":105,"minAge":106,"maxAge":10,"enrollmentInfo":107,"targetDuration":10,"studyType":110,"phases":10,"briefSummary":111,"conditions":112,"keywords":10,"overallStatus":51,"whyStopped":10,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":125},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of Care",null,"questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery.\n\nThe questionnaire will ask about your health, appetite, and quality of life. It should take about 3-5 minutes to complete.",[13],"Other: Standard of Care",{"label":15,"type":10,"description":11,"interventionNames":16},"Control group",[17],"Other: Control Group",[19,22],{"type":6,"name":9,"description":20,"armGroupLabels":21,"otherNames":10},"complete a questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery",[9],{"type":6,"name":23,"description":20,"armGroupLabels":24,"otherNames":10},"Control Group",[15],[26],{"name":27,"affiliation":5,"role":28},"Naruhiko Ikoma, MD","PRINCIPAL_INVESTIGATOR",[30],{"name":27,"role":31,"phone":32,"phoneExt":10,"email":33},"CONTACT","(832) 729-2675","nikoma@mdanderson.org",[35,49,64,81],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":10},"Mayo Clinic in Rochester","ACTIVE_NOT_RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-92.4699,44.02163,{"lat":47,"lon":46},{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":41,"countryCode":42,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"M D Anderson Cancer Center","RECRUITING","Houston","Texas","77030",{"type":44,"coordinates":56},[57,58],-95.36327,29.76328,{"lat":58,"lon":57},[61,63],{"name":27,"role":31,"phone":62,"phoneExt":10,"email":33},"832-729-2675",{"name":27,"role":28,"phone":10,"phoneExt":10,"email":10},{"facility":65,"status":51,"city":66,"state":10,"zip":67,"country":68,"countryCode":69,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Keio University School of Medicine","Tokyo","1600016","Japan","JP",{"type":44,"coordinates":71},[72,73],139.69171,35.6895,{"lat":73,"lon":72},[76,80],{"name":77,"role":31,"phone":78,"phoneExt":10,"email":79},"Satoru Matsuda, MD, PhD","+81 3-3353-1211","s.matsuda.a8@keio.jp",{"name":77,"role":28,"phone":10,"phoneExt":10,"email":10},{"facility":82,"status":51,"city":83,"state":10,"zip":84,"country":85,"countryCode":10,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"Yonsei University College of Medicine","Soeul","03722","South Korea",{"type":44,"coordinates":87},[88,89],126.7319,36.9168,{"lat":89,"lon":88},[92,96],{"name":93,"role":31,"phone":94,"phoneExt":10,"email":95},"Hyoung-II Kim, MD, PhD","+82-1599-1004","cairus@yuhs.ac",{"name":93,"role":28,"phone":10,"phoneExt":10,"email":10},{"type":98,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100455038","trans-pacific-multicenter-collaborative-study-of-minimally-invasive-proximal-versus-total-gastrectomy-for-proximal-gastric-and-gastroesophageal-junction-cancers-100455038",false,"NCT05205343","Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers","Inclusion:\n\n1. Able to speak and read English, Spanish, Japanese or Korean\n2. Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention\n3. Age ≥ 18\n\nExclusion:\n\n1. Participants with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract\n2. Participants with known narcotic dependence, with average daily dose \\> 5 mg oral morphine equivalent\n3. Participants deemed unable to comply with study and\u002For follow-up procedures, at investigators' discretion\n4. Participants who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)","ALL","18 Years",{"count":108,"type":109},20,"ESTIMATED","OBSERVATIONAL","To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.",[113,114,115],"Gastrostomy","Gastric","GastroEsophageal Cancer","2026-02-02",{"date":118,"type":119},"2026-02-04","ACTUAL",{"date":121,"type":119},"2022-05-11",{"date":123,"type":109},"2026-05-31",{"name":5,"class":6},4]